Elsevier to Flip Seven Subscription Journals to Open Access in 2014
Amsterdam, December 17, 2013
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that it will flip seven established subscription journals to a gold open access model starting from 1st January 2014.
These titles include Physics Letters B and Nuclear Physics B as part of Elsevier's participation in the SCOAP3 (Sponsoring Consortium for Open Access Publishing in Particle Physics) initiative. Other titles include Stem Cell Research, The International Journal of Infectious Diseases,Developmental Cognitive Neuroscience , Epidemics and EJC Supplements.
"This announcement is part of Elsevier's ongoing effort to help facilitate further implementation of open access options", said Philippe Terheggen, Managing Director of STM journals at Elsevier. "In areas where we have seen a clear uptake and support for open access publishing from authors, funders and the wider community we have made the decision to flip the journal. Our priority is always to focus on what authors need and to provide the best quality journal which will serve the community regardless of the business model."
Journals that are changed from subscription-based to open access will retain the same editorial standards and instead of through subscriptions, the publication costs of the journals will be covered through an article processing fees paid by the authors or, in the case of Physics Letters B and Nuclear Physics B, by the SCOAP3 consortium. Libraries will no longer need to subscribe to these titles, and past issues remain accessible to subscribers through their collection agreements.
"As high-energy physics journals flip to open access, this is a time of reflection," said Salvatore Mele, who led the development of the SCOAP3 initiative at CERN. "Hard work and close collaboration have brought this open access initiative into reality. Many different stakeholders have reached unprecedented consensus: libraries, funding agencies, research organizations and publishers such as Elsevier. All together they have made this possible."
About Open Access Publishing at Elsevier
Elsevier has been providing open access publishing options since 2005. Today, researchers can choose to publish open access in over 1,600 established peer-reviewed journals as well as 73 full open access journals and these numbers will continue to grow rapidly. All of Elsevier's open access publications have been peer reviewed, ensuring that the broader community not only reads the latest research but that it is factual, original and of the highest quality and ethical standards. For more information about Elsevier's open access program, visit www.elsevier.com/openaccess
Elsevier is a global information analytics business that helps institutions and professionals advance healthcare, open science and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support and professional education, including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 38,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com
+31 20 485 27 36